Autiero Monica, Waltenberger Johannes, Communi Didier, Kranz Andrea, Moons Lieve, Lambrechts Diether, Kroll Jens, Plaisance Stephane, De Mol Maria, Bono Françoise, Kliche Stefanie, Fellbrich Guido, Ballmer-Hofer Kurt, Maglione Domenico, Mayr-Beyrle Ulrike, Dewerchin Mieke, Dombrowski Saskia, Stanimirovic Danica, Van Hummelen Paul, Dehio Christoph, Hicklin Daniel J, Persico Graziella, Herbert Jean-Marc, Communi David, Shibuya Masabumi, Collen Désiré, Conway Edward M, Carmeliet Peter
The Center for Transgene Technology and Gene Therapy, Flanders Interuniversity Institute for Biotechnology, KULeuven, Leuven, B-3000, Belgium.
Nat Med. 2003 Jul;9(7):936-43. doi: 10.1038/nm884.
Therapeutic angiogenesis is likely to require the administration of factors that complement each other. Activation of the receptor tyrosine kinase (RTK) Flk1 by vascular endothelial growth factor (VEGF) is crucial, but molecular interactions of other factors with VEGF and Flk1 have been studied to a limited extent. Here we report that placental growth factor (PGF, also known as PlGF) regulates inter- and intramolecular cross talk between the VEGF RTKs Flt1 and Flk1. Activation of Flt1 by PGF resulted in intermolecular transphosphorylation of Flk1, thereby amplifying VEGF-driven angiogenesis through Flk1. Even though VEGF and PGF both bind Flt1, PGF uniquely stimulated the phosphorylation of specific Flt1 tyrosine residues and the expression of distinct downstream target genes. Furthermore, the VEGF/PGF heterodimer activated intramolecular VEGF receptor cross talk through formation of Flk1/Flt1 heterodimers. The inter- and intramolecular VEGF receptor cross talk is likely to have therapeutic implications, as treatment with VEGF/PGF heterodimer or a combination of VEGF plus PGF increased ischemic myocardial angiogenesis in a mouse model that was refractory to VEGF alone.
治疗性血管生成可能需要给予相互补充的因子。血管内皮生长因子(VEGF)激活受体酪氨酸激酶(RTK)Flk1至关重要,但其他因子与VEGF和Flk1的分子相互作用研究程度有限。在此我们报告,胎盘生长因子(PGF,也称为PlGF)调节VEGF RTKs Flt1和Flk1之间的分子间和分子内串扰。PGF激活Flt1导致Flk1的分子间转磷酸化,从而通过Flk1放大VEGF驱动的血管生成。尽管VEGF和PGF都结合Flt1,但PGF独特地刺激特定Flt1酪氨酸残基的磷酸化以及不同下游靶基因的表达。此外,VEGF/PGF异二聚体通过形成Flk1/Flt1异二聚体激活分子内VEGF受体串扰。分子间和分子内VEGF受体串扰可能具有治疗意义,因为在单独使用VEGF无效的小鼠模型中,用VEGF/PGF异二聚体或VEGF加PGF的组合治疗可增加缺血性心肌血管生成。